The total return over the past 12 months is -76.03% vs. +16.94% for the S&P 500. So far it's up -67.61% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (76.03%) | (57.63%) | (62.51%) | N/A | N/A | N/A |
| Total Return CAGR | (76.03%) | (57.63%) | (62.51%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Jasper Therapeutics, Inc. (JSPR)
| Year | Start price | End price | JSPR Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.83 | $0.59 | (67.61%) | +14.51% | (82.12%) |
| 2025 | $21.38 | $1.83 | (91.44%) | +17.72% | (109.16%) |
| 2024 | $7.89 | $21.38 | +170.98% | +24.89% | +146.09% |
| 2023 | $4.83 | $7.89 | +63.35% | +26.19% | +37.16% |
| 2022 | $78.50 | $4.83 | (93.85%) | (18.17%) | (75.68%) |
| 2021 | $100.10 | $78.50 | (21.58%) | +28.74% | (50.32%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
